Biomarkers and Echocardiography in the Postoperative Course of Pulmonary Resection Surgery


Background: The existence of different degrees of inflammatory reaction and right ventricular dysfunction after pulmonary resection is well known, though its detection and clinical relevance have not been sufficiently evaluated. The introduction of new biomarkers, particularly brain natriuretic peptide (BNP) and its prohormone (proBNP), together with dynamic imaging techniques such as echocardiography, could prove useful in assessing such response. The aim of this study is to describe the kinetic curve of these biomarkers during uncomplicated pulmonary resection surgery. Furthemore we have studied the right ventricular function by echocardiography in these patients Methods: Demographic data, antecedents and certain perioperative parameters, as well as plasma proBNP, troponin T and C-reactive protein (CRP) levels, were recorded in 38 patients who underwent pneumonectomy (n= 13 ) and lobectomy (n=25), before and 24, 48 and 72 hours after the operation. A transthoracic echocardiogram was carried out preoperatively and 72 hours after surgery. Results: ProBNP showed a significant increase 24 hours after surgery, with a maximum peak after 72 hours (p<0.001). CRP likewise increased after 24 hours, with an inflammatory peak after 48 hours (p<0.001). The magnitude of the increase in proBNP and CRP was independent of the extent of resection (pneumonectomy versus lobectomy). Echocardiography showed a slight yet statistically significant decrease in right ventricular function (determined by tricuspid annular plane systolic excursion, TAPSE) in the pneumonectomy subgroup (p=0.01). Conclusion: The plasma proBNP elevation curve allows simple evaluation of the degree and time course of right ventricular dysfunction in the immediate postoperative period of uncomplicated pulmonary resection surgery. In stable patients, magnitude of proBNP elevation has no clinical repercussions, while slight echocardiographic changes are detectable only in pneumonectomized patients. Further studies are needed to evaluate the usefulness of abnormal proBNP elevations in predicting cardiorespiratory complications at patients bedside during the immediate postoperative period.

Share and Cite:

D. Andaluz-Ojeda, F. Gandía, J. Duque, I. Gómez, B. Gregorio, J. Román and E. Villacorta, "Biomarkers and Echocardiography in the Postoperative Course of Pulmonary Resection Surgery," Open Journal of Thoracic Surgery, Vol. 1 No. 1, 2011, pp. 1-8. doi: 10.4236/ojts.2011.11001.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] C. E. Reed, H. E. Dorman and F. G. Spinale, “Effect of Pulmonary Resection on Right Ventricular Function,” The Annals Thoracic Surgery, Vol. 53, 1992, pp. 578-582. doi:10.1016/0003-4975(92)90314-T
[2] C. E. Reed, H. E. Dorman and F. G. Spinale, “Assesment of Rentricular Contractile Performance after Pulmonary Resection,” The Society of Thoracic Surgeons, Vol. 56, 1993, pp. 426-432.
[3] M. R. Cowie, A. D. Struthers, D. A. Wood, et al., “Value of Natriuretic Peptides in Assessment of Patients with Possiblen New Heart Failure in Primary Care,” Lancet Vol. 350, No. 9088, 1997, pp. 1347-1351.
[4] L. King and M. R. Wilkins, “Natriuretic Peptides Receptors and the Heart,” Heart, Vol. 87, NO. 4, 2002, pp. 314-315. doi:10.1136/heart.87.4.314
[5] A. Maisel, P. Krishnaswamy, R. Nowak, et al., “Rapid Measurement of B-Type Natriuretic Peptide in the Emer-gency Diagnosis of Heart Failure,” The New England Journal Medicine, Vol. 347, 2002, pp. 161-167. doi:10.1056/NEJMoa020233
[6] J. A. De Lemos, D. K. Mc Guire and M. H. Drazner, “B-Type Natriuretic Peptide in Cardiovascular Disease,” Lancet, Vol. 362, 2003, pp. 316-322.
[7] M. Ten Wolde, Tulevski II, J. W. Mulder, et al., “Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients with Pulmonary Embolism,” Circulation, Vol. 117, 2003, pp. 2082-2084. doi:10.1161/01.CIR.0000070020.79932.DB
[8] N. Kucher, G. Printzen and S. Z. Goldhaber, “Pronostic Role of Brain Natriuretic Peptide in Acute Pulmonary Embolism,” Circulation, Vol. 107, 2003, pp. 2545-2547.
[9] M. Bando, Y. Isii, Y. Sugiyama, et al., “Elevated Plasma Brain Natriuretic Levels in Chronic Respiratory Failure with Cor pulmonale,” Respiratory Medicine, Vol. 93,No. 7, 1999, pp. 507-514. doi:10.1016/S0954-6111(99)90094-X
[10] N. Nagaya, T. Nikishimi, M. Uematse, et al., “Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Pa-tients with Primary Pulmonary Hypertension,” Circulation, Vol. 102, 2000, pp. 865-870.
[11] M. A. Quinones, C. M. Otto, M. Stoddard, A. Wggoner and W. A. Zoghbi, “Recommendations for Quantification of Doppler Echocardiography: A Report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echo-cardiography,” Journal of American Society Echocardi-ogrdiography, Vol. 15, No. 2, 2002, pp. 167-184.
[12] S. Kaul, C. Tei, J. M. Hopkins and P. M. Shan, “Assessment of Right Ventricular Function Using Two Dimensional Echocardiography,” American Heart Journal, Vol. 107, No. 3, 1984, pp. 526-531. doi:10.1016/0002-8703(84)90095-4
[13] J. Meluzin, L. Spinarova, J. Bakala, J. Toman, J. Krejci, P. Hude, T. Kara and M. Soucek, “Pulsed Doppler Tissue Imaging of the Velocity of Tricuspid Annular Systolic Motion. A New, Rapid, and Non-Invasive Method of Evaluating Right Ventricular Systolic Function,” European Heart Journal, Vol. 22, No. 4, 2001, pp. 280-282. doi:10.1053/euhj.2000.2296
[14] K. Miyatake, M. Yamgishi, N. Tanaka, M. Uematsu, N. Yamazaki, Y. Mine, A. Sano and M. Hirama, “New Me-thod for Evaluating Left Ventricular Wall Motion by Color-Coded Tissue Doppler Imaging: In Vitro and In vivo Studies,” Journal American College Cardiology, Vol. 25, No. 3, 1995, pp. 717-724. doi:10.1016/0735-1097(94)00421-L
[15] O. M. Ueti, E. E. Camargo, A. Ueti Ade, E. C. de Lima-Filho and E. A. Nogueira, “Assessment of Right Ventricular Function with Doppler Echocardiographic Indices Derived from Tricuspid Annular Motion: Compari-son with Radionuclide Angiography,” Heart, Vol. 88, No. 3, 2002, pp. 244-248.
[16] B. Hoksch, R. Hahner and R. A. Schmid, “Procalcitonin and Brain Natriuretic Peptide as Parameters in the Post-operative Course of Patients with Major Pulmonary Resection,” Interact Cardiovasc Thoracic Surgery, Vol. 6, 2007, pp. 155-159. doi:10.1510/icvts.2006.143073
[17] K. Tayama, S. Takamori, M. Mitsuoka, et al., “Natriuretic Peptides after Pulmonary Resection,” The Annals Thoracic Surgery, Vol. 73, No. 5, 2002, pp. 1582-1586. doi:10.1016/S0003-4975(02)03417-3
[18] S. P. Souza, M. Davis and G. F. Baxter, “Autocrine and Paracrine Actions of Natriuretic Peptides in the Heart,” Pharmacology Therapeutics, Vol. 101, No. 2, 2004, pp. 113-129. doi:10.1016/j.pharmthera.2003.11.001
[19] J. Koglin, S. Pehlivanli, M. Schwaiblmair, M. Voseger, P. Cremer and W. vonScheidt, “Role of Brain Natriuretic Peptide in Risk Stratification of Patients with Congestive Heart Failure,” Journal American College Cardiology, Vol. 38, 2001, pp. 1934-1941. doi:10.1016/S0735-1097(01)01672-2
[20] C. E. Reed, F. G. Spinale and F. A. Crawford Jr., “Effect of Pulmonary Resection on Right Ventricular Function,” The Annals Thoracic Surgery, Vol. 53, No. 4, 1992, pp. 578-582. doi:10.1016/0003-4975(92)90314-T
[21] C. E. Reed, B. H. Dorman and F. G. Spinale, “Mechanisms of Right Ventricular Dysfunction after Pulmonary Resection,” The Annals Thoracic Surgery, Vol. 62, No. 1, 1996, pp. 225-231. doi:10.1016/0003-4975(96)00258-5
[22] J. Kowalewski, M. Brocki, T. Dryjanski, K. Kapron and S. Barcikowski, “Right Ventricular Morphology and Function after Pulmonary Resection,” European Journal of Cardio-Thoracic Surgery, Vol. 15, No. 1, 1999, pp. 444-448. doi:10.1016/S1010-7940(99)00032-9
[23] D. Amar, M. E. Burt, N. Roichaster, R. A. Reinsel, R. J. Ginsberg and R. S. Wilson, “Value of Perioperative Doppler Echocardiography in Patients Undergoing Major Lung Resection,” The Annals Thoracic Surgery, Vol. 61, 1996, pp. 516-520. doi:10.1016/0003-4975(95)00939-6
[24] A. Franke, W. Lante, S. Kupser, H. P. Becker, C. Wein-hold, A. Markewitz, “Procalcitonin Levels after Different Types of Conventional Thoracic Surgery,” Thoracic Cardiovasc Surgery, Vol. 56, No. 1, 2008, pp. 46-50. doi:10.1055/s-2007-989250
[25] S. Wan, J. L. LeClerc and J. L. Vincent, “Cytokine Responses to Cardiopulmonary Bypass: Lessons Learned from Cardiac Transplantation,” The Annals Thoracic Surgery, Vol. 63, 1997, pp. 269-276. doi:10.1016/S0003-4975(96)00931-9
[26] B. J. Grube, C. G. Cochane, R. D. Ye, et al., “Lipopoly-saccharide Binding Protein Expression in Primary Human Hepatocytes and HepG2 Hepatoma Cells,” The Journal of Biological Chemistry, Vol. 269, 1994, pp. 8477-8482

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.